A population‐based study of scoliosis among males diagnosed with a dystrophinopathy identified by the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
- 1 December 2021
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 65 (2) , 193-202
Abstract
Introduction/Aims Scoliosis is a common comorbidity among individuals diagnosed with a dystrophinopathy. We examined associations between clinical predictors and scoliosis in childhood-onset dystrophinopathy. Methods The progression and treatment of scoliosis were obtained from data collected by the US population-based Muscular Dystrophy Surveillance, Tracking, and Research Network. Associations between loss of independent ambulation (LoA) and corticosteroid use and scoliosis outcomes (ages at or exceeding Cobb angle thresholds [10°, 20°, 30°]; surgery) were estimated using Kaplan–Meier curve estimation and extended Cox regression modeling. Results We analyzed curvature data for 513 of 1054 individuals ascertained. Overall, approximately one-half had at least one radiograph and one-quarter had a curvature of at least 20°. The average maximum curvature was 25.0° (SD = 21.5°) among all individuals and 42.8° (SD = 18.8°) among those recommended for surgery. Higher adjusted hazards ratio of curvature (aHR(curvature) [95% confidence interval]) were found among individuals with LoA compared to those without LoA (aHR(10) = 6.2 [4.4, 8.7], aHR(20) = 15.3 [7.4, 31.7], aHR(30) = 31.6 [7.7, 128.9]), among individuals who did not use corticosteroids compared to those who did (aHR(10) = 1.2 [0.9, 1.7], aHR(20) = 1.8 [1.1, 2.7], aHR(30) = 2.3 [1.3, 4.0]), and among non-ambulatory individuals who used corticosteroids after LoA compared to those who did not (aHR(10) = 1.8 [1.2, 2.8], aHR(20) = 1.6 [1.0, 2.6], aHR(30) = 3.6 [1.6, 7.9]). Scoliosis surgery among individuals with LoA who did not use corticosteroids was more than double compared to those who used (aHR = 2.3 [1.3, 4.2]). Discussion Our retrospective observational study suggests corticosteroids may delay spinal curvature progression and need for scoliosis surgery. Continuing corticosteroids after LoA also showed potential benefits of delaying curvature progression, additional studies are needed to confirm this finding or address the magnitude of benefit.Keywords
Funding Information
- Centers for Disease Control and Prevention (DD000192, DD000191, DD000190, DD000189, DD000187)
This publication has 46 references indexed in Scilit:
- The Natural History of Cardiac and Pulmonary Function Decline in Patients With Duchenne Muscular DystrophySpine, 2011
- Impact of Steroids on Surgical Experiences of Patients With Duchenne Muscular DystrophyPediatric Neurology, 2010
- Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Case Definition in Surveillance for Childhood-Onset Duchenne/Becker Muscular DystrophyJournal of Child Neurology, 2010
- Update on the management of Duchenne muscular dystrophyArchives of Disease in Childhood, 2008
- Management of scoliosis in Duchenne muscular dystrophy: a large 10-year retrospective studyDevelopmental Medicine & Child Neurology, 2007
- The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Surveillance methodologyBirth Defects Research Part A: Clinical and Molecular Teratology, 2006
- Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocolsNeuromuscular Disorders, 2004
- Traitement chirurgical des scolioses de la dystrophie musculaire de DuchenneChirurgie, 1999
- Prevention of Rapidly Progressive Scoliosis in Duchenne Muscular Dystrophy by Prolongation of Walking with OrthosesJournal of Child Neurology, 1988
- PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHYThe Lancet, 1974